Clinical Trial Update: Safety, Tolerability, and Efficacy of GLS-012 and GLS-010 in Patients With Advanced Non-Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update on GLS-012 and GLS-010 in advanced non-small cell lung cancer to assess safety, tolerability, and preliminary efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• GLS-010
• GLS-012

Snippet

Sponsor: Guangzhou Gloria Biosciences Co., Ltd. | Conditions: Advanced Non-Small Cell Lung Cancer | Phase 1, Phase 2 | Status: UNKNOWN